Log in
Enquire now
Vaxxas

Vaxxas

Vaxxas is commercializing a novel vaccination technology that dramatically enhances the performance of existing and next-generation vaccines.

OverviewStructured DataIssuesContributors

Contents

vaxxas.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Consumer biotechnology
Consumer biotechnology
Technology
Technology
Vaccine
Vaccine
Biotechnology
Biotechnology
Biology
Biology
Healthcare
Healthcare
Drug delivery
Drug delivery
Location
United States
United States
Australia
Australia
Sydney
Sydney
Founder
Mark Kendall
Mark Kendall
Email Address
info@vaxxas.com
Investors
OneVentures
OneVentures
UniQuest
UniQuest
Founded Date
January 1, 2011
Total Funding Amount (USD)
22,820,000
Latest Funding Round Date
December 5, 2022
Latest Funding Type
Series C
Series C
Patents Assigned (Count)
1
Country
Australia
Australia

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
22,820,000

Vaxxas is commercializing novel technology that dramatically enhances the performance of existing and next-generation vaccines. The company believes its innovative needle-free technology will be fundamental to help the world in rethinking what's possible with vaccines.

Vaxxas' approach which has been validated in human clinical studies can enhance the efficiency and effectiveness of a vaccine's immune response. The company uses proprietary dry-coating technology that can eliminate or significantly reduce the need for vaccine refrigeration during storage and transportation - easing the resource and logistics burden of maintaining the vaccine "cold chain".

Vaxxas is targeting initial applications in infectious disease and oncology and has forged collaborations with leading global organizations in vaccine commercialization, including Merck/MSD, the United States Biomedical Advanced Research and Development Authority (BARDA), the World Health Organization (WHO), and the Bill and Melinda Gates Foundation.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Vaxxas

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.